387 related articles for article (PubMed ID: 33992699)
21. Trends in hospitalizations for chronic liver disease-related liver failure in the United States, 2005-2014.
Kim D; Cholankeril G; Li AA; Kim W; Tighe SP; Hameed B; Kwo PY; Harrison SA; Younossi ZM; Ahmed A
Liver Int; 2019 Sep; 39(9):1661-1671. PubMed ID: 31081997
[TBL] [Abstract][Full Text] [Related]
22. Risk factors for hepatocellular carcinoma by age, sex, and liver disorder status: A prospective cohort study in Korea.
Yi SW; Choi JS; Yi JJ; Lee YH; Han KJ
Cancer; 2018 Jul; 124(13):2748-2757. PubMed ID: 29669170
[TBL] [Abstract][Full Text] [Related]
23. Clinical Implications of Concomitant Alcohol Use, Obesity, and Viral Hepatitis.
Serfaty L
Gastroenterology; 2016 Jun; 150(8):1718-22. PubMed ID: 26873400
[No Abstract] [Full Text] [Related]
24. Outcomes of SARS-CoV-2 Infection in Patients With Chronic Liver Disease and Cirrhosis: A National COVID Cohort Collaborative Study.
Ge J; Pletcher MJ; Lai JC;
Gastroenterology; 2021 Nov; 161(5):1487-1501.e5. PubMed ID: 34284037
[TBL] [Abstract][Full Text] [Related]
25. The contribution of alcohol use disorder to decompensated cirrhosis among people with hepatitis C: An international study.
Alavi M; Janjua NZ; Chong M; Grebely J; Aspinall EJ; Innes H; Valerio HM; Hajarizadeh B; Hayes PC; Krajden M; Amin J; Law MG; George J; Goldberg DJ; Hutchinson SJ; Dore GJ
J Hepatol; 2018 Mar; 68(3):393-401. PubMed ID: 29107152
[TBL] [Abstract][Full Text] [Related]
26. Long-term prognostic value of the FibroTest in patients with non-alcoholic fatty liver disease, compared to chronic hepatitis C, B, and alcoholic liver disease.
Munteanu M; Pais R; Peta V; Deckmyn O; Moussalli J; Ngo Y; Rudler M; Lebray P; Charlotte F; Thibault V; Lucidarme O; Ngo A; Imbert-Bismut F; Housset C; Thabut D; Ratziu V; Poynard T;
Aliment Pharmacol Ther; 2018 Nov; 48(10):1117-1127. PubMed ID: 30334263
[TBL] [Abstract][Full Text] [Related]
27. Outcomes following SARS-CoV-2 infection in liver transplant recipients: an international registry study.
Webb GJ; Marjot T; Cook JA; Aloman C; Armstrong MJ; Brenner EJ; Catana MA; Cargill T; Dhanasekaran R; García-Juárez I; Hagström H; Kennedy JM; Marshall A; Masson S; Mercer CJ; Perumalswami PV; Ruiz I; Thaker S; Ufere NN; Barnes E; Barritt AS; Moon AM
Lancet Gastroenterol Hepatol; 2020 Nov; 5(11):1008-1016. PubMed ID: 32866433
[TBL] [Abstract][Full Text] [Related]
28. Increased mortality in HIV/HCV-coinfected compared to HCV-monoinfected patients in the DAA era due to non-liver-related death.
Chalouni M; Pol S; Sogni P; Fontaine H; Lacombe K; Marc-Lacombe J; Esterle L; Dorival C; Bourlière M; Bani-Sadr F; de Ledinghen V; Zucman D; Larrey D; Salmon D; Carrat F; Wittkop L;
J Hepatol; 2021 Jan; 74(1):37-47. PubMed ID: 32798585
[TBL] [Abstract][Full Text] [Related]
29. Clinical Effect of Hepatitis B Virus on COVID-19 Infected Patients: A Nationwide Population-Based Study Using the Health Insurance Review & Assessment Service Database.
Choe JW; Jung YK; Yim HJ; Seo GH
J Korean Med Sci; 2022 Jan; 37(4):e29. PubMed ID: 35075828
[TBL] [Abstract][Full Text] [Related]
30. Surveillance improves survival of patients with hepatocellular carcinoma: a prospective population-based study.
Hong TP; Gow PJ; Fink M; Dev A; Roberts SK; Nicoll A; Lubel JS; Kronborg I; Arachchi N; Ryan M; Kemp WW; Knight V; Sundararajan V; Desmond P; Thompson AJ; Bell SJ
Med J Aust; 2018 Oct; 209(8):348-354. PubMed ID: 30309301
[TBL] [Abstract][Full Text] [Related]
31. Ten years of hospital admissions for liver cirrhosis in Portugal.
Silva MJ; Rosa MV; Nogueira PJ; Calinas F
Eur J Gastroenterol Hepatol; 2015 Nov; 27(11):1320-6. PubMed ID: 26275086
[TBL] [Abstract][Full Text] [Related]
32. Clinical characteristics and outcomes of invasively ventilated patients with COVID-19 in Argentina (SATICOVID): a prospective, multicentre cohort study.
Estenssoro E; Loudet CI; Ríos FG; Kanoore Edul VS; Plotnikow G; Andrian M; Romero I; Piezny D; Bezzi M; Mandich V; Groer C; Torres S; Orlandi C; Rubatto Birri PN; Valenti MF; Cunto E; Sáenz MG; Tiribelli N; Aphalo V; Reina R; Dubin A;
Lancet Respir Med; 2021 Sep; 9(9):989-998. PubMed ID: 34224674
[TBL] [Abstract][Full Text] [Related]
33. Association between Prolonged Intermittent Renal Replacement Therapy and All-Cause Mortality in COVID-19 Patients Undergoing Invasive Mechanical Ventilation: A Retrospective Cohort Study.
Yang Y; Shi J; Ge S; Guo S; Xing X; Wang Y; Cheng A; Liu Q; Li J; Ning Y; He F; Xu G
Blood Purif; 2021; 50(4-5):481-488. PubMed ID: 33271549
[TBL] [Abstract][Full Text] [Related]
34. Profile and value of FIB-4 in patients with dual chronic hepatitis C and B.
Liu CJ; Tseng TC; Yang WT; Su TH; Yang HC; Liu CH; Chen PJ; Chen DS; Kao JH
J Gastroenterol Hepatol; 2019 Feb; 34(2):410-417. PubMed ID: 30151861
[TBL] [Abstract][Full Text] [Related]
35. Patterns and predictors of mortality and disease progression among patients with non-alcoholic fatty liver disease.
Canbay A; Kachru N; Haas JS; Sowa JP; Meise D; Ozbay AB
Aliment Pharmacol Ther; 2020 Oct; 52(7):1185-1194. PubMed ID: 33016540
[TBL] [Abstract][Full Text] [Related]
36. Alcohol use disorders and the risk of progression of liver disease in people with hepatitis C virus infection - a systematic review.
Llamosas-Falcón L; Shield KD; Gelovany M; Manthey J; Rehm J
Subst Abuse Treat Prev Policy; 2020 Jun; 15(1):45. PubMed ID: 32605584
[TBL] [Abstract][Full Text] [Related]
37. Baseline Characteristics and Outcomes of 1591 Patients Infected With SARS-CoV-2 Admitted to ICUs of the Lombardy Region, Italy.
Grasselli G; Zangrillo A; Zanella A; Antonelli M; Cabrini L; Castelli A; Cereda D; Coluccello A; Foti G; Fumagalli R; Iotti G; Latronico N; Lorini L; Merler S; Natalini G; Piatti A; Ranieri MV; Scandroglio AM; Storti E; Cecconi M; Pesenti A;
JAMA; 2020 Apr; 323(16):1574-1581. PubMed ID: 32250385
[TBL] [Abstract][Full Text] [Related]
38. Alcohol-Associated Cirrhosis.
Lucey MR
Clin Liver Dis; 2019 Feb; 23(1):115-126. PubMed ID: 30454826
[TBL] [Abstract][Full Text] [Related]
39. Undefined/non-malignant hepatic nodules are associated with early occurrence of HCC in DAA-treated patients with HCV-related cirrhosis.
Sangiovanni A; Alimenti E; Gattai R; Filomia R; Parente E; Valenti L; Marzi L; Pellegatta G; Borgia G; Gambato M; Terreni N; Serio I; Belli L; Oliveri F; Maimone S; Brunacci M; D'Ambrosio R; Forzenigo LV; Russo FP; Rumi M; Barone M; Fracanzani AL; Raimondo G; Giannini EG; Brunetto MR; Villa E; Biganzoli E; Colombo M; Lampertico P
J Hepatol; 2020 Sep; 73(3):593-602. PubMed ID: 32243959
[TBL] [Abstract][Full Text] [Related]
40. Impact of etiological treatment on prognosis.
Su CW; Yang YY; Lin HC
Hepatol Int; 2018 Feb; 12(Suppl 1):56-67. PubMed ID: 28702738
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
